3D tumor model biofabrication

M Li, X Song, S Jin, K Ye - Bio-Design and Manufacturing, 2021 - Springer
Animal models have been extensively used in cancer pathology studies and drug discovery.
These models, however, fail to reflect the complex human tumor microenvironment and do …

High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)

L Wang, Y Cao, W Guo, J Xu - Journal of Cancer Research and Clinical …, 2023 - Springer
Background Cuproptosis induced by FDX1 is a newly discovered mechanism regulating cell
death. However, the role of FDX1 in the pathogenesis of colon adenocarcinoma (COAD) …

Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy

T Guo, J Xu - Cancer and Metastasis Reviews, 2024 - Springer
Tumor microenvironment (TME) has been demonstrated to play a significant role in tumor
initiation, progression, and metastasis. Cancer-associated fibroblasts (CAFs) are the major …

Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer

D Bausch, S Fritz, L Bolm, UF Wellner… - Angiogenesis, 2020 - Springer
Abstract Introduction The inhibition of Hedgehog (Hh) signaling in pancreatic ductal
adenocarcinoma (PDAC) reduces desmoplasia and promotes increased vascularity. In …

An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal …

S Liu, Q Hu, Z Xie, S Chen, Y Li, N Quan… - Journal of Cancer …, 2023 - Springer
Purpose Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors.
Endoplasmic reticulum stress (ERS) plays an essential role in PDAC progression. Here, we …

From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy

SO Imodoye, KA Adedokun, IO Bello - Histochemistry and Cell Biology, 2024 - Springer
Despite the tremendous clinical successes recorded in the landscape of cancer therapy,
tumor heterogeneity remains a formidable challenge to successful cancer treatment. In …

RETRACTED ARTICLE: Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker

J Li, H Hou, J Sun, Z Ding, Y Xu, G Li - Functional & Integrative Genomics, 2023 - Springer
The purpose of this study was to investigate the expression significance, predictive value,
immunologic function, and biological role of transmembrane protein 158 (TMEM158) in the …

Metabolic interactions between tumor and stromal cells in the tumor microenvironment

D Mishra, D Banerjee - Tumor Microenvironment: Cellular, Metabolic and …, 2021 - Springer
In this chapter, we provide information about metabolic reprogramming in cancer cells,
molecular interactions between tumor and stromal cells in the tumor microenvironment …

CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival

J Wedig, S Jasani, D Mukherjee, H Lathrop… - Cancer Immunology …, 2024 - Springer
Pancreatic cancer is an aggressive disease with a 5 year survival rate of 13%. This poor
survival is attributed, in part, to limited and ineffective treatments for patients with metastatic …

Immunological combination treatment holds the key to improving survival in pancreatic cancer

MH Sodergren, N Mangal, H Wasan… - Journal of Cancer …, 2020 - Springer
Advances in surgery, peri-operative care and systemic chemotherapy have not significantly
improved the prognosis of pancreatic cancer for several decades. Early clinical trials of …